Viewing Study NCT04850495


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2026-02-26 @ 4:19 PM
Study NCT ID: NCT04850495
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2021-04-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
Sponsor: Yazeed Sawalha
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module